Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Revenue Quarterly
0
200M
400M
600M
Q3 '21: 129.8M
Q4 '21: 140.1M
Q1 '22: 152.2M
Q2 '22: 186.4M
Q3 '22: 198.6M
Q4 '22: 201.8M
Q1 '23: 197.3M
Q2 '23: 249.9M
Q3 '23: 264.5M
Q4 '23: 254.1M
Q1 '24: 275.1M
Q2 '24: 324.9M
Q3 '24: 338.2M
Q4 '24: 342.8M
Q1 '25: 355.2M
Q2 '25: 415.8M
Q3 '25: 423.6M
Q4 '25: 443.6M
Q1 '26: 464.4M
Q2 '26: 550.9M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Gross Profit Quarterly
0
60M
120M
180M
Q3 '21: 39M
Q4 '21: 34.3M
Q1 '22: 31M
Q2 '22: 45M
Q3 '22: 50.6M
Q4 '22: 54.4M
Q1 '23: 45.7M
Q2 '23: 71.2M
Q3 '23: 75.2M
Q4 '23: 59.1M
Q1 '24: 71.8M
Q2 '24: 90.3M
Q3 '24: 90.1M
Q4 '24: 87.9M
Q1 '25: 90M
Q2 '25: 120M
Q3 '25: 106.8M
Q4 '25: 107.1M
Q1 '26: 107.5M
Q2 '26: 151.1M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Revenue minus cost of sales. This filer tags no gross profit of its own..
Operating Income Quarterly
-120M
-80M
-40M
0
40M
80M
120M
Q3 '21: -114.7M
Q4 '21: -7.1M
Q1 '22: -14.2M
Q2 '22: 2.7M
Q3 '22: 5.2M
Q4 '22: 3.8M
Q1 '23: -232K
Q2 '23: 19.6M
Q3 '23: 24.7M
Q4 '23: 2.2M
Q1 '24: 25.6M
Q2 '24: 32.2M
Q3 '24: 32.5M
Q4 '24: 15.8M
Q1 '25: 31.1M
Q2 '25: 54.7M
Q3 '25: 41.5M
Q4 '25: 34M
Q1 '26: 34.3M
Q2 '26: 70.4M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-15M
0
15M
30M
45M
Q3 '21: -11.1M
Q4 '21: -1.6M
Q1 '22: -4.9M
Q2 '22: -906K
Q3 '22: 1.8M
Q4 '22: -2.8M
Q1 '23: -3.8M
Q2 '23: 2.8M
Q3 '23: 4.2M
Q4 '23: -1.4M
Q1 '24: 7.1M
Q2 '24: 11.9M
Q3 '24: 12.6M
Q4 '24: 3.6M
Q1 '25: 15.4M
Q2 '25: 25.6M
Q3 '25: 17.5M
Q4 '25: 21.4M
Q1 '26: 16.1M
Q2 '26: 37.4M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Cost of Revenue Quarterly
0
150M
300M
450M
Q3 '21: 90.8M
Q4 '21: 105.8M
Q1 '22: 121.2M
Q2 '22: 141.4M
Q3 '22: 148.1M
Q4 '22: 147.5M
Q1 '23: 151.5M
Q2 '23: 178.6M
Q3 '23: 189.3M
Q4 '23: 195M
Q1 '24: 203.3M
Q2 '24: 234.6M
Q3 '24: 248.2M
Q4 '24: 254.8M
Q1 '25: 265.2M
Q2 '25: 295.8M
Q3 '25: 316.8M
Q4 '25: 336.5M
Q1 '26: 356.9M
Q2 '26: 399.8M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-40M
0
40M
80M
120M
Q3 '21: 16.1M
Q4 '21: 8.1M
Q1 '22: -756K
Q2 '22: 17.5M
Q3 '22: 26.1M
Q4 '22: 17.1M
Q1 '23: 3.1M
Q2 '23: 42.8M
Q3 '23: 49.1M
Q4 '23: 45M
Q1 '24: 41.2M
Q2 '24: 59.5M
Q3 '24: 83.5M
Q4 '24: 62.2M
Q1 '25: 36.9M
Q2 '25: 89.9M
Q3 '25: 89.1M
Q4 '25: 79.6M
Q1 '26: 84.7M
Q2 '26: 112.2M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-45M
-30M
-15M
0
15M
30M
45M
Q3 '21: -23.1M
Q4 '21: -36.3M
Q1 '22: -40.7M
Q2 '22: -26.4M
Q3 '22: -24.7M
Q4 '22: -36.1M
Q1 '23: -40.2M
Q2 '23: -16.3M
Q3 '23: -16.4M
Q4 '23: -15.7M
Q1 '24: -16.3M
Q2 '24: -4.9M
Q3 '24: 26.4M
Q4 '24: 19.5M
Q1 '25: -8.7M
Q2 '25: 35.7M
Q3 '25: 18.9M
Q4 '25: 8.5M
Q1 '26: 27.7M
Q2 '26: 39.9M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
50M
100M
150M
Q3 '21: 45.8M
Q1 '22: 48.1M
Q2 '22: 50.9M
Q3 '22: 54.4M
Q1 '23: 56.7M
Q2 '23: 57.4M
Q3 '23: 60.2M
Q1 '24: 83.4M
Q2 '24: 102.4M
Q3 '24: 114.3M
Q1 '25: 121.5M
Q2 '25: 126.8M
Q3 '25: 127.4M
Q1 '26: 127.4M
Q2 '26: 134.8M
Q3 '21
Q2 '22
Q1 '23
Q3 '23
Q2 '24
Q1 '25
Q3 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-0.50
-0.25
0.00
0.25
0.50
0.75
Q2 '22: -0.40
Q3 '22: -0.13
Q4 '22: -0.09
Q1 '23: -0.06
Q2 '23: 0.01
Q3 '23: 0.05
Q4 '23: 0.03
Q1 '24: 0.18
Q2 '24: 0.25
Q3 '24: 0.29
Q4 '24: 0.33
Q1 '25: 0.38
Q2 '25: 0.46
Q3 '25: 0.49
Q4 '25: 0.64
Q1 '26: 0.64
Q2 '26: 0.72
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.